CoChat

Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target

Open access
Wen, Yiping, Cai, Jing, Hou, Yaya, Huang, Zaiju, Wang, Zehua · 2017 · Oncotarget
Cited by 90

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

// Yiping Wen 1,* , Jing Cai 1,* , Yaya Hou 1 , Zaiju Huang 1 and Zehua Wang 1 1 Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China * These authors have contributed equally to this work Correspondence to: Zehua Wang, email: // Keywords : EZH2, cancer stem cells, sphere, histone lysine methylation, polycomb repressive complex Received : November 02, 2016 Accepted : March 02, 2017 Published : March 22, 2017 Abstract Epigenetic modifications in cancer stem cells largely result in phenotypic and functional heterogeneity in many solid tumors. Increasing evidence indicates that enhancer of zeste homolog 2 (EZH2), the catalytic subunit of Polycomb repressor complex 2, is highly expressed in cancer stem cells of numerous malignant tumors and has a critical function in cancer stem cell expansion and maintenance. Here, we review up-to-date information regarding EZH2 expression patterns, functions, and molecular mechanisms in cancer stem cells in various malignant tumors and discuss the therapeutic potential of targeting EZH2 in tumors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.16467

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 90

Metadata

Authors
Wen, Y., Cai, J., Hou, Y., Huang, Z., & Wang, Z.
Venue
Oncotarget
Published
2017-03-22
Volume
8
Issue
23
Pages
37974-37990
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2603097935
Cited by
90
References
8
FWCI
3.88
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. https://app.cochat.ai/papers/10.18632/oncotarget.16467
The paper
Wen, Y., Cai, J., Hou, Y., Huang, Z., & Wang, Z. (2017). Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. Oncotarget. https://doi.org/10.18632/oncotarget.16467

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.